Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
181
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Four-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population

Tobias Busch1 Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Region Västra Götaland, SwedenORCID Iconhttps://orcid.org/0000-0003-2459-1848View further author information
ORCID Icon,
Dragana Skiljic1 Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Region Västra Götaland, Sweden;2 Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-9220-7767View further author information
ORCID Icon,
Thiemo Rudolph1 Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Region Västra Götaland, SwedenORCID Iconhttps://orcid.org/0000-0002-9214-7178View further author information
ORCID Icon,
Anders Bergström1 Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Region Västra Götaland, Sweden;3 Department of Ophthalmology, Skåne University Hospital, Lund, SwedenORCID Iconhttps://orcid.org/0000-0002-0835-0035View further author information
ORCID Icon &
Madeleine Zetterberg1 Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Region Västra Götaland, Sweden;2 Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
View further author information
Pages 1897-1910 | Received 14 Mar 2023, Accepted 30 May 2023, Published online: 03 Jul 2023

References

  • Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53(Suppl 1):S3–10. doi:10.1016/j.survophthal.2008.08.006
  • Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
  • Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–713. doi:10.1001/archopht.120.6.701
  • Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505–1516. doi:10.1016/S0140-6736(18)32213-X
  • Kirwan JF, Lockwood AJ, Shah P, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120(12):2532–2539. doi:10.1016/j.ophtha.2013.07.049
  • Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–814 e801. doi:10.1016/j.ajo.2011.10.024
  • Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189–206. doi:10.2147/OPTH.S80490
  • Chaudhary A, Salinas L, Guidotti J, Mermoud A, Mansouri K. XEN Gel Implant: a new surgical approach in glaucoma. Expert Rev Med Devices. 2018;15(1):47–59. doi:10.1080/17434440.2018.1419060
  • Reitsamer H, Vera V, Ruben S, et al. Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study. Acta Ophthalmol. 2021;100(1):e233–e245. doi:10.1111/aos.14886
  • Gabbay IE, Goldberg M, Allen F, et al. Efficacy and safety data for the Ab interno XEN45 gel stent implant at 3 Years: a retrospective analysis. Eur J Ophthalmol;2021. 11206721211014381. doi:10.1177/11206721211014381
  • Nicolaou S, Khatib TZ, Lin Z, et al. A retrospective review of XEN implant surgery: efficacy, safety and the effect of combined cataract surgery. Int Ophthalmol. 2022;42(3):881–889. doi:10.1007/s10792-021-02069-5
  • Gillmann K, Bravetti GE, Rao HL, Mermoud A, Mansouri K. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors. Acta Ophthalmol. 2021;99(4):e531–e539. doi:10.1111/aos.14605
  • Buffault J, Baudouin C, Labbe A. XEN((R)) gel stent for management of chronic open angle glaucoma: a review of the literature. J Fr Ophtalmol. 2019;42(2):e37–e46. doi:10.1016/j.jfo.2018.12.002
  • Chen XZ, Liang ZQ, Yang KY, et al. The outcomes of XEN gel stent implantation: a systematic review and meta-analysis. Front Med. 2022;9:804847. doi:10.3389/fmed.2022.804847
  • Astrom S, Linden C. Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: i. baseline report. Acta Ophthalmol Scand. 2007;85(8):828–831. doi:10.1111/j.1600-0420.2007.00992.x
  • Busch T, Skiljic D, Rudolph T, Bergström A, Zetterberg M. Learning curve and one-year outcome of XEN 45 gel stent implantation in a Swedish population. Clin Ophthalmol. 2020;14:3719–3733. doi:10.2147/OPTH.S267010
  • Vera V, Sheybani A, Lindfield D, Stalmans I, Ahmed IIK. Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation. Clin Ophthalmol. 2019;13:685–694. doi:10.2147/OPTH.S195457
  • Reitsamer H, Sng C, Vera V, et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–996. doi:10.1007/s00417-019-04251-z
  • Gabbay IE, Allen F, Morley C, Pearsall T, Bowes OM, Ruben S. Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol. 2020;104(8):1125–1130. doi:10.1136/bjophthalmol-2019-313870
  • Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I. XEN((R)) gel stent: a comprehensive review on its use as a treatment option for refractory glaucoma. Clin Ophthalmol. 2020;14:1805–1832. doi:10.2147/OPTH.S178348
  • Thatcher MD, Coupal DJ, Cheng Y, Podbielski DW. Short-term efficacy and safety of open conjunctiva Ab externo XEN45 gel stent implantation in glaucoma patients. J Glaucoma. 2022;31(9):757–762. doi:10.1097/IJG.0000000000002064

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.